Results 181 to 190 of about 31,387 (227)

Criteria Used to Determine Platinum Eligibility in Patients with Metastatic Urothelial Carcinoma: Results of a Physician Survey in Five European Countries. [PDF]

Eur Urol Open Sci
Gupta S, Powles T, Kearney M, Panattoni L, Land N, Flottemesch T, Sullivan P, Kirker M, Bharmal M, Guenther S, Costa N, Grande E.   +11 more
europepmc   +1 more source

Prognostic Factors in Metastatic Urothelial Carcinoma Treated Without Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (M-VAC): A Single-Center Retrospective Study. [PDF]

Cureus
Bugday I, Inanc M, Ozkan M, Bozkurt O, Cosar R, Firat ST, Mutlu E, Eser M, Disli AK, Cengiz M.   +9 more
europepmc   +1 more source

Progress of antibody-drug conjugates in the treatment of locally advanced or metastatic urothelial carcinoma: opportunities and challenges. [PDF]

Discov Oncol
Zeng F, Han Q, Ding T, Tian C, Jiang M.
europepmc   +1 more source

Efficacy and safety of a novel treatment scheme of RC48-ADC plus PD-1 inhibitors in metastatic urothelial carcinoma: a multicenter real-world study. [PDF]

Ther Adv Med Oncol
Lin J, Bai J, Li X, Wen Y, Ye Y, Chen S, Chen H, Qiu Q, Huang J, Ye Y, Liu R, Kang D, Chen R, Lu Q, Su Y, Zhang W, Wei Y, Zhu S, Chen J.   +18 more
europepmc   +1 more source

Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma. [PDF]

Front Immunol
Liu Z, Cong X, Chen C, Yin J, Liu Z.
europepmc   +1 more source

Editorial Comment on Comparison of Perioperative Chemotherapy Regimens for Muscle‐Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials

International Journal of Urology, Volume 33, Issue 3, March 2026.
Yusuke Goto
wiley   +1 more source

Metastatic urothelial carcinoma in multiple appendicular muscles of a cat. [PDF]

JFMS Open Rep
Hernández EM, Ginel PJ, Blanco B, Millán Y, Jiménez MT, Mozos E.   +5 more
europepmc   +1 more source

Correction to "Efficacy of Trametinib in a Metastatic Urothelial Carcinoma Patient With a BRAF Mutation: A Case Report". [PDF]

IJU Case Rep
europepmc   +1 more source

Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort. [PDF]

Eur Urol Open Sci
Fiala O, Grillone F, Fujita K, Grande E, Giannatempo P, Taha T, Myint ZW, Büttner T, de Liaño AG, Kanesvaran R, Facchini G, Yano A, Formisano L, Poprach A, Conteduca V, Pirshtuk A, Studentova H, Kopecky J, Sammarco E, Mota A, Incorvaia L, Nasso C, Maffezzoli M, Ghose A, Soares A, Buti S, Marques Monteiro FS, Massari F, Gupta S, Bellmunt J, Banna GL, Santoni M.   +31 more
europepmc   +1 more source

Impact of durable response of first-line systemic treatment for patients with locally advanced or metastatic urothelial carcinoma: data update of EV-302/KEYNOTE-A39 trial. [PDF]

Transl Androl Urol
Miyake M.
europepmc   +1 more source